Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort

被引:0
|
作者
Masquelier, B
Chaix, ML
Burgard, M
Lechenadec, J
Doussin, A
Simon, F
Cottalorda, J
Izopet, J
Tamalet, C
Douard, D
Fleury, H
Mayaux, MJ
Blanche, S
Rouzioux, C
机构
[1] Ctr Hosp Univ Necker Paris, Virol Lab, Paris, France
[2] Ctr Hosp Univ Kremlin Bicetre, INSERM U292, Virol Lab, Le Kremlin Bicetre, France
[3] Ctr Hosp Univ Bichat Paris, Virol Lab, Paris, France
[4] Ctr Hosp Univ Nice, Virol Lab, Nice, France
[5] Ctr Hosp Univ Toulouse, Virol Lab, Toulouse, France
[6] Ctr Hosp Univ Marseille, Virol Lab, Marseille, France
[7] Hop Pellegrin, Serv Pediat, Bordeaux, France
[8] Hop Necker Enfants Malad, Serv Pediat, Paris, France
[9] Ctr Hosp Univ Bordeaux, Hop Pellegrin, Virol Lab, F-33076 Bordeaux, France
关键词
HIV-1 mother-child transmission; zidovudine; drug resistance; AJ276519; AJ276552; variability;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A retrospective study was set up to investigate the frequency of zidovudine (ZDV)-resistant HIV-1 in infected newborns after ZDV prophylaxis in the French Perinatal Cohort study. Nucleotide sequence analysis was carried out from 34 infants' isolates and 18 maternal plasma samples. Mutations related to ZDV resistance were found in the HIV-1 reverse transcriptase in 7 of 34 children (20%). Evidence of mother-child transmission of ZDV-resistant HIV-1 was found in 4 cases. Phylogenetic analysis showed that 14 of 34 HIV-1 isolates from the infants belonged to non-B subtypes. The presence of ZDV resistance-encoding mutations in the newborn isolates was associated with a longer total duration of exposure to ZDV. In a context of a wide HIV-1 variability, ZDV resistance can be one of the factors contributing to mother-child transmission.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 50 条
  • [41] Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
    De Maat, MMR
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    Van Gorp, ECM
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 552P - 552P
  • [42] Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
    David J. Back
    Andrew Owen
    Saye H. Khoo
    [J]. Clinical Pharmacokinetics, 2006, 45 : 213 - 214
  • [43] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Kappelhoff, BS
    Huitema, ADR
    Yalvaç, Z
    Prins, JM
    Mulder, JW
    Meenhorst, PL
    Beijnen, JH
    [J]. CLINICAL PHARMACOKINETICS, 2005, 44 (08) : 849 - 861
  • [44] Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa
    Erikstrup, Christian
    Kallestrup, Per
    Zinyama, Rutendo
    Gomo, Exnevia
    Mudenge, Boniface
    Gerstoft, Jan
    Ullum, Henrik
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (04) : 478 - 483
  • [45] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Kappelhoff, BS
    Huitema, ADR
    Yalvaç, Z
    Prins, JM
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 467 - 467
  • [46] Effect of bisphosphonates on the treatment of BMD abnormalities in an HIV-1-infected cohort
    Beckett, H.
    Abdul-Latif, M.
    Mandalia, S.
    Singh, G. K. J.
    Bower, M.
    Nelson, M.
    [J]. HIV MEDICINE, 2013, 14 : 39 - 39
  • [47] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Back, DJ
    Owen, A
    Khoo, SH
    [J]. CLINICAL PHARMACOKINETICS, 2006, 45 (02) : 213 - 214
  • [48] Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
    de Maat, MMR
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    van Gorp, ECM
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (04) : 378 - 385
  • [49] Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohort
    Desquilbet, L
    Deveau, C
    Goujard, C
    Hubert, JB
    Derouineau, J
    Meyer, L
    [J]. AIDS, 2002, 16 (17) : 2329 - 2333
  • [50] Predictors of genotypic resistance and virological response in antiretroviral naive HIV-1 infected patients treated with zidovudine plus didanosine.
    Vidal, C
    Pumarola, T
    Amedo, M
    Gil, C
    Garcia, F
    Zamora, L
    Cruceta, A
    Gatell, JM
    [J]. AIDS, 1998, 12 : S26 - S26